Aird William C
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Blood. 2003 May 15;101(10):3765-77. doi: 10.1182/blood-2002-06-1887. Epub 2003 Jan 23.
Severe sepsis, defined as sepsis with acute organ dysfunction, is associated with high morbidity and mortality rates. The development of novel therapies for sepsis is critically dependent on an understanding of the basic mechanisms of the disease. The pathophysiology of severe sepsis involves a highly complex, integrated response that includes the activation of a number of cell types, inflammatory mediators, and the hemostatic system. Central to this process is an alteration of endothelial cell function. The goals of this article are to (1) provide an overview of sepsis and its complications, (2) discuss the role of the endothelium in orchestrating the host response in sepsis, and (3) emphasize the potential value of the endothelium as a target for sepsis therapy.
严重脓毒症定义为伴有急性器官功能障碍的脓毒症,其发病率和死亡率均很高。新型脓毒症治疗方法的研发严重依赖于对该疾病基本机制的理解。严重脓毒症的病理生理学涉及高度复杂的综合反应,包括多种细胞类型、炎症介质及止血系统的激活。这一过程的核心是内皮细胞功能的改变。本文的目的是:(1)概述脓毒症及其并发症;(2)讨论内皮细胞在协调脓毒症宿主反应中的作用;(3)强调以内皮细胞作为脓毒症治疗靶点的潜在价值。